Experiments for taxon Galtonia candicans (LILIACEAE)

102 experiments

Experiment	Worktypes	Pharmacology	Organism (specimen)	Compound
249212	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	GALTONIOSIDE A
258765	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
277922	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Galtonia candicans (LILIACEAE)	CHOLEST-5-EN-16-BETA-OL-3-O-ACETYL-ALPHA-L-RHAMNOPYRANOSIDE,3-BETA-[(BETA-D-GLUCOPYRANOSYL)-OXY]-22(S)-HYDROXY:
1107250	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMICROBIAL ACTIVITY(UNSPECIFIED)	Galtonia candicans (LILIACEAE)
258744	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
277940	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CHOLEST-5-EN-22-ONE,16-BETA-[(ALPHA-L-ARABINOPYRANOSYL)-OXY]-3-BETA-[(BETA-D-GLUCOPYRANOSYL)-OXY]-17-ALPHA-HYDROXY:
258733	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
277943	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Galtonia candicans (LILIACEAE)	CHOLEST-5-EN-3-BETA-OL-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSIDE,24-NOR: 16-BETA-23-EPOXY-18-23-DIHYDROXY-22-(2-METHYL-1-PROPENYL): (22S-23R):
258758	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
258750	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
277925	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CHOLESTA-5-24-DIEN-16-BETA-OL-3-O-ACETYL-ALPHA-L-RHAMNOPYRANOSIDE,3-BETA-[(BETA-D-GLUCOPYRANOSYL)-OXY]-22(S)-HYDROXY:
249194	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	GALTONIOSIDE A
258761	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
258754	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
277936	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CHOLEST-5-EN-22-ONE,3-BETA-[(BETA-D-GLUCOPYRANOSYL)-OXY]-17-ALPHA-HYDROXY-16-BETA-[(O-(2-O-3-4-DIMETHOXY-BENZOYL-BETA-D-XYLOPYRANOSYL)-(1-2)-2-O-ACETYL-ALPHA-L-ARABINOPYRANOSYL)-OXY:
249208	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	GALTONIOSIDE A
258743	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
258755	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
277921	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)
258732	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
249216	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	GALTONIOSIDE A
249203	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	GALTONIOSIDE A
258766	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
249198	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	GALTONIOSIDE A
277932	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)
249200	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	GALTONIOSIDE A
249187	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Galtonia candicans (LILIACEAE)	GALTONIOSIDE A
258760	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
258745	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
249213	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	GALTONIOSIDE A
258764	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
277929	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Galtonia candicans (LILIACEAE)	CHOLEST-5-EN-16-BETA-OL-BETA-D-GLUCOPYRANOSIDE,1-BETA-[(O-BETA-D-GLUCOPYRANOSYL)-OXY]-3-BETA-22(S)-DIHYDROXY:
258731	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
258729	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
258734	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
258742	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
277937	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Galtonia candicans (LILIACEAE)	CHOLEST-5-EN-22-ONE,3-BETA-[(BETA-D-GLUCOPYRANOSYL)-OXY]-17-ALPHA-HYDROXY-16-BETA-[(O-BETA-D-XYLOPYRANOSYL(1-2)-2-O-ACETYL-ALPHA-L-ARABINOPYRANOSYL)-OXY]:
249207	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	GALTONIOSIDE A
258726	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)
249193	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	GALTONIOSIDE A
258725	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)
277935	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Galtonia candicans (LILIACEAE)	CHOLEST-5-EN-22-ONE,3-BETA-[(BETA-D-GLUCOPYRANOSYL)-OXY]-17-ALPHA-HYDROXY-16-BETA-[(O-(2-O-3-4-DIMETHOXY-BENZOYL-BETA-D-XYLOPYRANOSYL)-(1-2)-2-O-ACETYL-ALPHA-L-ARABINOPYRANOSYL)-OXY:
277924	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Galtonia candicans (LILIACEAE)	CHOLESTA-5-24-DIEN-16-BETA-OL-3-O-ACETYL-ALPHA-L-RHAMNOPYRANOSIDE,3-BETA-[(BETA-D-GLUCOPYRANOSYL)-OXY]-22(S)-HYDROXY:
258759	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
258736	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
249204	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	GALTONIOSIDE A
249197	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	GALTONIOSIDE A
258756	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
277926	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Galtonia candicans (LILIACEAE)	CHOLESTA-5-24-DIEN-16-BETA-OL-BETA-D-GLUCOPYRANOSIDE,1-BETA-[(BETA-D-GLUCOPYRANOSYL)-OXY]-3-BETA-22(S)-DIHYDROXY:
258753	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
258747	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
249199	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	GALTONIOSIDE A
249196	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	GALTONIOSIDE A
277920	VOUCHER SPECIMEN REPORTED FOR		Galtonia candicans (LILIACEAE)
258735	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
277945	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Galtonia candicans (LILIACEAE)	GALTONIOSIDE A
258730	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
258763	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
258746	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
258748	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
258737	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
277931	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)
249192	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	GALTONIOSIDE A
249210	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	GALTONIOSIDE A
249201	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	GALTONIOSIDE A
277942	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CHOLEST-5-24-DIEN-16-BETA-OL-BETA-D-GLUCOPYRANOSIDE,3-BETA-22(S)-DIHYDROXY-1-BETA-[(ALPHA-L-RHAMNOPYRANOSYL)-OXY]:
258738	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
258752	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
277934	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CHOLEST-5-EN-22-ONE,16-BETA-[(O-(2-O-TRANS-CINNAMOYL-BETA-D-XYLOPYRANOSYL)-(1-2)-2-O-ACETYL-ALPHA-L-ARABINOPYRANOSYL)-OXY]-3-BETA-[(BETA-D-GLUCOPYRANOSYL)-OXY]-17-ALPHA-HYDROXY:
277923	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CHOLEST-5-EN-16-BETA-OL-BETA-D-GLUCOPYRANOSIDE,1-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-6)-BETA-D-GLUCOPYRANOSYL)-OXY]-3-BETA-22(S)-DIHYDROXY:CHOLEST-5-EN-16-BETA-OL-3-O-ACETYL-ALPHA-L-RHAMNOPYRANOSIDE,3-BETA-[(BETA-D-GLUCOPYRANOSYL)-OXY]-22(S)-HYDROXY:CHOLEST-5-EN-16-BETA-OL-BETA-D-GLUCOPYRANOSIDE,1-BETA-[(O-BETA-D-GLUCOPYRANOSYL)-OXY]-3-BETA-22(S)-DIHYDROXY:CHOLESTA-5-24-DIEN-16-BETA-OL-BETA-D-GLUCOPYRANOSIDE,1-BETA-[(BETA-D-GLUCOPYRANOSYL)-OXY]-3-BETA-22(S)-DIHYDROXY:CHOLESTA-5-24-DIEN-16-BETA-OL-BETA-D-GLUCOPYRANOSIDE,1-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-6)-BETA-D-GLUCOPYRANOSYL)-OXY]-3-BETA-22(S)-DIHYDROXY:
258757	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
249214	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	GALTONIOSIDE A
249205	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	GALTONIOSIDE A
258727	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
1107252	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BACTERIAL INHIBITION-INDUCTION-PHAGE INHIBITION	Galtonia candicans (LILIACEAE)
277938	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CHOLEST-5-EN-22-ONE,3-BETA-[(BETA-D-GLUCOPYRANOSYL)-OXY]-17-ALPHA-HYDROXY-16-BETA-[(O-BETA-D-XYLOPYRANOSYL(1-2)-2-O-ACETYL-ALPHA-L-ARABINOPYRANOSYL)-OXY]:
277927	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Galtonia candicans (LILIACEAE)	CHOLESTA-5-24-DIEN-16-BETA-OL-BETA-D-GLUCOPYRANOSIDE,1-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-6)-BETA-D-GLUCOPYRANOSYL)-OXY]-3-BETA-22(S)-DIHYDROXY:
258741	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
258749	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
258762	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
277944	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CHOLEST-5-EN-3-BETA-OL-O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSIDE,24-NOR: 16-BETA-23-EPOXY-18-23-DIHYDROXY-22-(2-METHYL-1-PROPENYL): (22S-23R):
249202	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	GALTONIOSIDE A
1107251	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PROPHAGE INDUCTION	Galtonia candicans (LILIACEAE)
249195	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	GALTONIOSIDE A
249189	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	GALTONIOSIDE A
249211	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	GALTONIOSIDE A
249206	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	GALTONIOSIDE A
277930	VOUCHER SPECIMEN REPORTED FOR		Galtonia candicans (LILIACEAE)
249191	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	GALTONIOSIDE A
258751	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
249215	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	GALTONIOSIDE A
249190	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	GALTONIOSIDE A
277941	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Galtonia candicans (LILIACEAE)	CHOLEST-5-24-DIEN-16-BETA-OL-BETA-D-GLUCOPYRANOSIDE,3-BETA-22(S)-DIHYDROXY-1-BETA-[(ALPHA-L-RHAMNOPYRANOSYL)-OXY]:
277933	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Galtonia candicans (LILIACEAE)	CHOLEST-5-EN-22-ONE,16-BETA-[(O-(2-O-TRANS-CINNAMOYL-BETA-D-XYLOPYRANOSYL)-(1-2)-2-O-ACETYL-ALPHA-L-ARABINOPYRANOSYL)-OXY]-3-BETA-[(BETA-D-GLUCOPYRANOSYL)-OXY]-17-ALPHA-HYDROXY:
258740	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
258724	PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
258739	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
249188	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	GALTONIOSIDE A
277939	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Galtonia candicans (LILIACEAE)	CHOLEST-5-EN-22-ONE,16-BETA-[(ALPHA-L-ARABINOPYRANOSYL)-OXY]-3-BETA-[(BETA-D-GLUCOPYRANOSYL)-OXY]-17-ALPHA-HYDROXY:
258728	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	CANDICANOSIDE A
249209	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Galtonia candicans (LILIACEAE)	GALTONIOSIDE A
277928	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Galtonia candicans (LILIACEAE)	CHOLEST-5-EN-16-BETA-OL-BETA-D-GLUCOPYRANOSIDE,1-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-6)-BETA-D-GLUCOPYRANOSYL)-OXY]-3-BETA-22(S)-DIHYDROXY:

Experiments for taxon Galtonia candicans (LILIACEAE)

Experiments (102 results)

Filters

Worktypes (12)

Pharmacology (5)

Compounds (15)

Organisms (5)